Valuation : Active Biotech AB

Market Cap 119M 12.29M 10.57M 9.97M 9.08M 16.98M 1.17B 17.14M 45.7M 596M 46.15M 45.14M 1.89B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 119M 12.29M 10.57M 9.97M 9.08M 16.98M 1.17B 17.14M 45.7M 596M 46.15M 45.14M 1.89B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
83.01%
Yield 2026 *
-
Yield 2027 * -
1 week-11.32%
Current month-12.01%
1 month-16.57%
3 months-29.83%
6 months-1.85%
Current year-2.07%
1 week 4.36
Extreme 4.355
5.06
1 month 4.36
Extreme 4.355
5.69
3 years 3.7
Extreme 3.7
52.95
5 years 3.7
Extreme 3.7
52.95
10 years 3.7
Extreme 3.7
427.11
Manager TitleAgeSince
Chief Executive Officer 64 2017-06-30
Director of Finance/CFO 75 1999-12-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 70 2011-04-06
Chairman 61 2019-05-22
Director/Board Member 76 2019-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
1/25/21 Buy

Director

24,261 -
1/25/21 Buy

Director

525,000 -
1/25/21 Buy

Director

935,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.93%-11.20%-69.11%-82.04% 12.29M
-0.25%-1.36%+44.08%+102.76% 68.24B
+0.98%-3.31%+31.95%+75.72% 62.23B
-1.18%+0.47%-12.78%+384.69% 27.8B
-1.05%-4.43%+30.56%+10.07% 24.86B
-1.76%-6.30%-4.55%-19.75% 24.22B
+0.24%-3.70%+14.47%-19.56% 19.36B
-1.86%-2.22%+202.03%+353.89% 17.28B
-1.94%-4.94%-5.29%+495.65% 14.46B
-1.54%-2.88%+52.33%+159.75% 14.23B
Average -0.93%-3.30%+28.37%+146.12% 30.3B
Weighted average by Cap. -0.50%-3.10%+35.68%+137.03%

Financials

2026 *2027 *
Net sales - -
Net income -33.2M -3.44M -2.95M -2.79M -2.54M -4.75M -328M -4.79M -12.78M -167M -12.9M -12.62M -529M 18.2M 1.88M 1.62M 1.53M 1.39M 2.6M 180M 2.63M 7M 91.33M 7.07M 6.92M 290M
Net Debt - -
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
-
Date Price Change Volume
26-09-11 SEK 4.360 -3.22% 14,925
26-09-10 SEK 4.505 -5.06% 92,616
26-09-09 SEK 4.745 -1.86% 34,803
26-09-08 SEK 4.835 -2.42% 27,201
26-09-07 SEK 4.955 +0.92% 12,275
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Net sales - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!